# FDA Inspection 1220146 - Elite Spine LLC - August 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/elite-spine-llc/efd6da3d-96bf-430d-bb54-17057ab8bd70
Source feed: FDA_Inspections

> FDA Inspection 1220146 for Elite Spine LLC on August 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220146
- Company Name: Elite Spine LLC
- Inspection Date: 2023-08-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1220146 - 2023-08-21](https://www.keypedia.com/records/fda_inspections/elite-spine-llc/9e906184-4fd8-4978-9362-2cb2ca46d69c)
- [FDA Inspection 1018942 - 2017-06-15](https://www.keypedia.com/records/fda_inspections/elite-spine-llc/ab6b8b9a-4eff-464f-8c17-131b7909e550)
- [FDA Inspection 992243 - 2016-11-16](https://www.keypedia.com/records/fda_inspections/elite-spine-llc/f466e248-b550-44c9-90ea-30f504ba471e)
- [FDA Inspection 992243 - 2016-11-16](https://www.keypedia.com/records/fda_inspections/elite-spine-llc/405b1951-f729-4265-ade3-9781087cf0b0)

Company: https://www.keypedia.com/companies/elite-spine-llc/fd9f76f6-3beb-4d69-809a-d9a8d728f1c7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d